Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Current Opinion in Oncology|February 8, 2006
Antiangiogenic drugs in non-small cell lung cancer treatmentTina Cascone, Teresa Troiani, Maria Pia Morelli, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 8, 2023
Next-Generation Approaches to Immuno-Oncology in GI CancersJ Randolph Hecht, Jasmine Mitchell, Maria Pia Morelli, et al.Expert Opinion on Drug Discovery|March 15, 2013
Epidermal growth factor receptor inhibitors in non-small-cell lung cancerTina Cascone, Erika Martinelli, Maria Pia Morelli, et al.Scientific Reports|April 28, 2021
Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitorsDespina Michailidou, Ali Raza Khaki, Maria Pia Morelli, et al.Cancer Biotherapy & Radiopharmaceuticals|January 14, 2020
The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint PathwayMassimo Fantini, Justin M David, Christina M Annunziata, et al.Cancers|October 27, 2022
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201Kwong Y Tsang, Massimo Fantini, Anjum Zaki, et al.Journal of Cellular Physiology|April 3, 2008
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cellsTina Cascone, Maria Pia Morelli, Floriana Morgillo, et al.Frontiers in Immunology|March 12, 2026
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancerJamie Hur, Massimo Fantini, Lidia Hernandez, et al.Journal of Cellular Physiology|May 12, 2006
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinasesMaria Pia Morelli, Tina Cascone, Teresa Troiani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2010
Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cellsErika Martinelli, Teresa Troiani, Floriana Morgillo, et al.Pageof 2